As of 30 Sep 2025, 139 institutional investors reported holding 45,852,231 shares of Humacyte, Inc. - COM (HUMA).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 229,024 | $227,516 | -$75,533 | $0.96 | 17 |
| 2025 Q3 | 45,852,231 | $79,792,130 | -$20,565,963 | $1.74 | 139 |
| 2025 Q2 | 56,964,566 | $119,040,607 | -$1,729,520 | $2.09 | 155 |
| 2025 Q1 | 60,715,449 | $103,532,610 | +$24,167,031 | $1.70 | 162 |
| 2024 Q4 | 42,086,100 | $212,644,738 | +$30,413,725 | $5.05 | 161 |
| 2024 Q3 | 35,792,230 | $194,660,851 | +$23,756,856 | $5.44 | 144 |
| 2024 Q2 | 31,200,014 | $149,783,561 | +$47,689,027 | $4.80 | 121 |
| 2024 Q1 | 23,275,197 | $72,383,175 | +$17,113,382 | $3.11 | 96 |
| 2023 Q4 | 26,282 | $74,641 | $2.84 | 1 | |
| 2023 Q3 | 16,610,977 | $48,671,942 | +$6,778,097 | $2.93 | 83 |
| 2023 Q2 | 14,355,721 | $41,155,636 | +$6,447,350 | $2.86 | 74 |
| 2023 Q1 | 12,062,725 | $37,416,893 | +$153,753 | $3.09 | 68 |
| 2022 Q4 | 11,860,351 | $25,020,069 | -$3,074,841 | $2.11 | 69 |
| 2022 Q3 | 11,776,439 | $38,392,556 | -$5,167,507 | $3.26 | 66 |
| 2022 Q2 | 13,422,846 | $43,083,190 | +$8,036,964 | $3.21 | 73 |
| 2022 Q1 | 10,475,028 | $73,904,016 | +$6,104,185 | $7.06 | 67 |
| 2021 Q4 | 9,406,587 | $68,195,600 | +$7,059,436 | $7.25 | 56 |
| 2021 Q3 | 7,198,591 | $77,547,000 | +$77,536,073 | $11.61 | 32 |